Joey CohenMedication Adherence
Paul TheisenPatient Acquisition
Frank BurrellScientific Storytelling
Matt TurnerPatient Affordability
David LinetskyPoint-of-Care Marketing
Suma Ramadas, PhDMedical Affairs
Amy GilesIncreasing Engagement
Stacey GandlerBrand Nourishment
Daniel SontupeMarket Access
Bud BilanichSuccess Coach
Matthew DurhamOmnidynamic Marketing
Pat PurcellMeeting Engagement
Liz KaneImpactful Strategy
Brenda SnowAuthentic Patient Voice
TYME’s novel metabolic-based investigational cancer therapy, SM-88, demonstrated encouraging results and a well-tolerated safety ...
- Estimated Market Launch 2nd-half 2018 Provides Access to 20,000 Dialysis Patients - WIXOM, ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email
